Varex Imaging (NASDAQ:VREX) Raised to “Strong-Buy” at Wall Street Zen

Varex Imaging (NASDAQ:VREX) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday.

A number of other research firms also recently commented on VREX. Jefferies Financial Group reissued a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a research note on Monday, February 2nd. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Oppenheimer dropped their price target on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $16.17.

Varex Imaging Trading Down 2.6%

Shares of NASDAQ:VREX opened at $13.17 on Friday. The company has a 50 day moving average of $13.30 and a 200-day moving average of $12.21. The firm has a market cap of $551.82 million, a P/E ratio of -8.03 and a beta of 0.90. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $14.56. The company has a current ratio of 3.89, a quick ratio of 1.87 and a debt-to-equity ratio of 0.75.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.19 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. The business had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. As a group, analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Institutional Trading of Varex Imaging

Several large investors have recently added to or reduced their stakes in VREX. Invesco Ltd. lifted its position in shares of Varex Imaging by 8.1% in the fourth quarter. Invesco Ltd. now owns 151,891 shares of the company’s stock worth $1,770,000 after purchasing an additional 11,318 shares in the last quarter. Mackenzie Financial Corp increased its holdings in shares of Varex Imaging by 58.2% during the 4th quarter. Mackenzie Financial Corp now owns 29,060 shares of the company’s stock valued at $346,000 after acquiring an additional 10,691 shares during the last quarter. Empowered Funds LLC grew its holdings in Varex Imaging by 5.9% during the fourth quarter. Empowered Funds LLC now owns 230,376 shares of the company’s stock valued at $2,684,000 after purchasing an additional 12,800 shares during the last quarter. Zacks Investment Management bought a new position in Varex Imaging in the 4th quarter worth $398,000. Finally, Tudor Investment Corp ET AL bought a new position in shares of Varex Imaging in the fourth quarter worth about $863,000.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.